carbachol has been researched along with Brain Damage, Chronic in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wasterlain, CG | 2 |
| Farber, DB | 2 |
| Fairchild, MD | 1 |
| Fairchild, D | 1 |
2 reviews available for carbachol and Brain Damage, Chronic
| Article | Year |
|---|---|
Synaptic mechanisms in the kindled epileptic focus: a speculative synthesis.
Topics: Animals; Anticonvulsants; Biomechanical Phenomena; Brain Damage, Chronic; Calcium; Carbachol; Electr | 1986 |
Cholinergic kindling: what has it taught us about epilepsy?
Topics: Amygdala; Animals; Brain Damage, Chronic; Carbachol; Epilepsy; Hippocampus; Humans; Kindling, Neurol | 1985 |